ICD-10-CM code · FY2027
G93.2 Benign intracranial hypertension
BillableValid for claims as a specific diagnosis code
About G93.2
Ask EvidencePulse about disorders of brain
Answers from the published evidence, with every study linked. The question goes into the box; nothing is sent until you press Ask.
Coding notes for G93.2
Applicable to Other names for conditions reported with this code.
- Pseudotumor
Excludes1 Not coded here: never report these together with this code (use the code given instead).
Chapter 6 notes (apply to every code in it)
Excludes2 Not part of this condition, but a patient can have both: report both codes when both apply.
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Related codes in G93
- G93.0 Cerebral cystsBillable
- G93.1 Anoxic brain damage, not elsewhere classifiedBillable
- G93.3 Postviral and related fatigue syndromesHeader
- G93.4 Other and unspecified encephalopathyHeader
- G93.5 Compression of brainBillable
- G93.6 Cerebral edemaBillable
- G93.7 Reye's syndromeBillable
- G93.8 Other specified disorders of brainHeader
- G93.9 Disorder of brain, unspecifiedBillable
Latest research on disorders of brain
- Fexofenadine and famotidine lack clinical trial evidence for menopausal symptoms
- 2 Minute Medicine Rewind August 17, 2026
- Glucagon-like peptide-1 receptor agonists show potential in reducing substance use disorders
- 2 Minute Medicine: Pharma Roundup – Geopolitical instability in the Strait of Hormuz threatens global generic drug supply, daraxonrasib improves pancreatic cancer survival, sparsentan (Filspari) approved for focal segmental glomerulosclerosis, glucagon-like peptide-1 receptor agonists linked to reduced substance use disorders, and orforglipron (Foundayo) expands oral weight loss therapy options
- The Scan by 2 Minute Medicine®: TikTok “Fibermaxxing” trend targets gut microbiome diversity, Jennifer Aniston’s “Strength for 50+” ritual spotlights photobiomodulation, American Lung Association issues respiratory warning over viral “mouth taping” fad, and Psychiatric Times highlights initiative to close the schizophrenia mortality gap
2MM+
Read the research behind every diagnosis
2MM+ gives you every study summary in full, Classics downloads of the landmark trials, EvidencePulse and HypeCheck, and ad-free reading.
See 2MM+ plans